IIR Globe IIR Data IIR
social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon social media icon

You are Trying to View a Free Article

Botox King Allergan Plumps up Beauty Biz with $2.5 Billion Zeltiq Fat Buster Buy

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 302 Words

SUGAR LAND--February 15, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Allergan plc (NYSE:AGN) (Dublin, Ireland) continues its buying spree with the $2.5 billion bid for Zeltiq Aesthetics (NASDAQ: ZLTQ) (Pleasanton, California). Why Zeltiq? The company complements Allergan's medical aesthetic portfolio, as its lead product is the CoolSculpting System, an FDA-cleared system that reduces unwanted fat. Using patented cooling technology, it is a non-invasive alternative to liposuction.


Login or Register for Instant Access

Subscribe Now! All Fields Required...

Standard Membership - Free

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current Economic Indicators
  • Free Daily Industrial Articles
  • Monthly Industrial Newsletter